OSIMERTINIB 80

Product Details:

Drug Type Generic Drugs
Ingredients OSIMERTINIB 80
Physical Form Tablets
Function Cancer Treatment
Recommended For NON SMALL CELL LUNG CANCER
Dosage Missed Dose Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Overdose Seek emergency medical treatment or contact the doctor in case of an overdose.
Suitable For Adults
Share Your Product:

287.04-314.39 USD ($)/Box

Get a Price/Quote

Request To Call Back Send Inquiry

OSIMERTINIB 80 Price And Quantity

Price 287.04-314.39 USD ($)/Box
Minimum Order Quantity 2 Box

OSIMERTINIB 80 Product Specifications

Storage Instructions ROOM TEMP. 10 -30 C
Drug Type Generic Drugs
Physical Form Tablets
Dosage Missed Dose Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Overdose Seek emergency medical treatment or contact the doctor in case of an overdose.
Suitable For Adults
Quantity 10 Boxes
Ingredients OSIMERTINIB 80
Recommended For NON SMALL CELL LUNG CANCER
Function Cancer Treatment

OSIMERTINIB 80 Trade Information

Payment Terms Cash in Advance (CID)
Supply Ability 50 Box Per Week
Delivery Time 3 Week
Packaging Details 1*10*3/BOX
Main Export Market(s) Western Europe North America Eastern Europe Middle East Central America South America Asia Australia Africa
Main Domestic Market All India

Product Description

In Non-small cell lung cancer

Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Tagrisso 80mg Tablet helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.

SIDE EFFECTS OF TAGRISSO TABLET

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youâ€™re worried about them

Common side effects of Tagrisso

Diarrhea
Loss of appetite
Rash
Stomatitis (Inflammation of the mouth)

HOW TO USE TAGRISSO TABLET

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tagrisso 80mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

HOW TAGRISSO TABLET WORKS

Tagrisso 80mg Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Other Products in 'Pharmaceutical Tablets' category

AMOXAPINE TAB Price : 13.66-16.39 USD ($)/Box Minimum Order Quantity : 5 Drug Type : Generic Drugs Storage Instructions : ROOM TEMP. 10 30 C Dosage : Missed Dose Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Overdose Seek emergency medical treatment or contact the doctor in case of an overdose. Suitable For : Adults Quantity : 100 Boxes Ingredients : AMOXAPINE Function : Other Physical Form : Tablets Recommended For : DEPRESSION

Send Inquiry

Sitagliptin 50 Tablets Price : 3.41-3.68 USD ($)/Box Minimum Order Quantity : 5 Drug Type : Generic Drugs Storage Instructions : ROOM TEMP. 10 30 C Dosage : Missed Dose Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Overdose Seek emergency medical treatment or contact the doctor in case of an overdose. Suitable For : Suitable For All Quantity : 50 Boxes Ingredients : SITAGLIPTIN Function : Other Physical Form : Tablets Recommended For : DIABETIC MILITIS

Send Inquiry

EFAVIRENZ 600 Price : 25.96-28.69 USD ($)/Bottle Minimum Order Quantity : 5 Drug Type : Specific Drug Storage Instructions : ROOM TEMP. 10 30 C Dosage : Missed Dose It is advised not to miss any dose. If you missed any dose, you should contact your doctor immediately. Overdose Seek emergency medical treatment or contact the doctor in case of an overdose. Suitable For : Women, Adults, Aged Person Quantity : 50 Unit Ingredients : EFAVIRENZ 600 Function : AntiViral Physical Form : Tablets Recommended For : HIV infection

Send Inquiry

Abiraterone Acetate 250mg Price : 259.59-273.26 USD ($)/Bottle Minimum Order Quantity : 3 Drug Type : Specific Drug Storage Instructions : ROOM TEMP. 10 30 C Dosage : Prostate Cancer Metastatic castrationresistant prostate cancer Zytiga Indicated in combination with prednisone for patients with metastatic castrationresistant prostate cancer (CRPC) 1000 mg (two 500mg tablets or four 250mg tablets) PO qDay with prednisone 5 mg PO q12hr Yonsa Indicated in combination with methylprednisolone for the treatment of patients with metastatic CRPC 500 mg (four 125mg tablets) PO qDay in combination with methylprednisolone 4 mg PO BID Metastatic highrisk castrationsensitive prostate cancer Zytiga Indicated in combination with prednisone for patients with metastatic highrisk castrationsensitive prostate cancer (CSPC) 1000 mg (two 500mg tablets or four 250mg tablets) PO qDay with prednisone 5 mg PO q12hr Dosage Modifications Strong CYP3A4 inducers Coadministration with strong CYP3A4 inducers (eg, phenytoin, carbamazepine, rifampin, rifabutin, rifapentine, phenobarbital): Avoid if possible; if strong CYP3A4 inducer must be administered, increase abiraterone dosage frequency of abiraterone Reduce dose back to the previous dose and frequency, if the concomitant strong CYP3A4 inducer is discontinued Yonsa Increase from 500 mg qDay to 500 mg BID Zytiga Increase from 1000 mg qDay to 1000 mg BID Hepatic impairment (Zytiga) Baseline LFTs Mild (ChildPugh A): No dosage adjustment necessary Moderate (ChildPugh B): Reduce starting dose to 250 mg PO qDay; monitor ALT, AST, and bilirubin prior to start of treatment, qWeek for the first month, q2Weeks for the following 2 months of treatment and monthly thereafter If elevations in ALT and/or AST >5x ULN or total bilirubin >3x ULN occur in patients with baseline moderate hepatic impairment, discontinue abiraterone and do not retreat patients Severe (ChildPugh C): Do not use Increased LFTs during treatment ALT and/or AST >5x ULN or total bilirubin >3x ULN: Interrupt treatment; reinitiate at reduced dose of 750 mg PO qDay following return of LFTs to baseline or to AST/ALT ≤2.5x ULN and total bilirubin ≤1.5x ULN For patients who resume treatment, monitor serum transaminases and bilirubin at least q2Weeks for 3 months, and then monthly thereafter If hepatotoxicity recurs at 750 mg/day, may restart at 500 mg/day (after LFTs decrease as above) If hepatoxicity recurs at reduced dose of 500 mg/day, discontinue treatment Permanently discontinue treatment for patients who develop a concurrent elevation of ALT >3x ULN and total bilirubin >2x ULN in the absence of biliary obstruction or other causes responsible for the concurrent elevation Hepatic impairment (Yonsa) Baseline Moderate (ChildPugh Class B): Reduce 125 mg PO qDay; monitor ALT, AST, and bilirubin prior to the start of treatment, every week for the first month, q2Weeks for the following 2 months of treatment and monthly thereafter If elevations in ALT and/or AST >5x ULN or total bilirubin >3x ULN occur in patients with baseline moderate hepatic impairment: Discontinue treatment and do not retreat patients with abiraterone Severe (ChildPugh Class C): Do not use Increased LFTs during treatment ALT and/or AST >5x ULN or total bilirubin >3x ULN): Interrupt treatment; restart at a reduced dose of 375 mg qDay following return of liver function tests to the patient’s baseline or to AST and ALT ≤2.5x ULN and total bilirubin ≤1.5x ULN For patients who resume treatment, monitor serum transaminases and bilirubin at least q2Weeks for 3 months, and then monthly thereafter If hepatotoxicity recurs on 375 mg/day, may be restart aeduced dose of 250 mg/day (after LFTs decrease as above) I Suitable For : Adults, Aged Person Quantity : 5 Boxes Ingredients : ABIRATERONE 250 Function : Cancer Treatment Physical Form : Tablets

Send Inquiry

SEND INQUIRY CALL ME FREE